Feature | March 11, 2010| Brian D. Hoit, M.D., professor of medicine, physiology and biophysics, Case Western Reserve University

Breakthrough in Ultrasound Provides Quantitative Cardiac Data

3D wall motion tracking more accurately evaluates ventricular function in a variety of cardiovascular diseases.

A 3D model of the left ventricle acquired with Toshibas 3D wall motion tracking technology for the Aplio Artida ultrasound system shows normal circumferential strain, while negative strain is color coded yellow/red.

Normal dyssynchrony is demonstrated using Toshibas 3D wall motion tracking for the Aplio Artida ultrasound system. The left ventricle is color coded all green showing timing is in sync, while dyssynchrony would be color coded red.

The Aplio Artida ultrasound system offers 3D wall motion tracking to help more accurately measure ventricular function by removing subjective analysis.

Since the introduction of cardiac ultrasound, investigators have sought to quantify cardiac function in three dimensions. The recent development of a new technology called 3D wall motion tracking (3DWMT), which displays quantitative echo data from 3D ultrasound data sets, has tremendous potential to more accurately evaluate ventricular function in a wide variety of cardiovascular diseases.

University Hospitals Case Medical Center in Cleveland, Ohio, recently implemented 3DWMT in its clinical studies. Physicians anticipate that removing subjectivity, minimizing interpretative variability and comprehensively and efficiently measuring strain, 3DWMT will revolutionize cardiac ultrasound diagnosis.

Benefits Over 2D Strain Imaging

The echocardiographic evaluation of regional myocardial function relies largely on the visual detection of endocardial wall motion abnormalities. However, this technique is subjective and demands complete visualization of the endocardium, and wall motion and thickening are subject to changes in cardiac loading and heart rate. Measurement of myocardial deformation (strain and strain rate) using 2D echocardiography has the potential to overcome these limitations. Because of 3D cardiac geometry and complex myofiber arrangements, there are multiple components or directions of strain (circumferential, longitudinal, and radial) that may be normal (i.e. orthogonal or perpendicular) or shear (i.e. torsional). While 2D strain (speckle tracking) and strain rate (tissue Doppler) imaging overcomes much of the subjectivity and variability inherent in assessing endocardial motion, these methods fail to address the complexities of cardiac geometry and motion. Not surprisingly, neglecting 3D wall motion may miss critical information and reduce accuracy.

However, imaging a moving 3D structure from a tomographic 2D plane creates obvious challenges. 3DWMT provides the physician and sonographer 3D depictions of the heart and graphical and parametric displays of myocardial deformation over time, all captured within a single cardiac cycle (4D mode) or from four stitched subvolumes (full 4D mode) and thus has the potential to meet these challenges. For example, using 2D acquisition methods there is the possibility of introducing error to strain measurements when the heart swings out of the imaging plane. When capturing the entire heart with 3DWMT, this issue is eliminated. An important advantage of 3DWMT is that the time for acquisition and analysis of longitudinal, circumferential and radial strains is reduced. In addition, the effects of twisting (and torsion) motion can be quantified.

3DWMT for Ischemic Heart Disease

Based on these considerations, 3DWMT affords the potential for a more robust evaluation of cardiac function than does any 2D echocardiographic technique. Acquiring quantitative data in one heart beat eliminates the need to piece (or stitch) the data together spatially and temporally from separate beats, and therefore may improve diagnostic accuracy. Owing to its sensitivity, strain analysis detects early, subclinical disease; as a result it has important potential applications in coronary artery disease, hypertensive heart disease, and cardiomyopathy.

One of the most important clinical applications of 3DWT is the assessment of ischemic heart disease. Ventricular volumes, ejection fraction and regional wall motion is rapidly assessed. Unique parameters of global ventricular systolic and diastolic function include rotation, twist and torsion. Global and regional vectors of strain and displacement in the radial, longitudinal and circumferential direction are simultaneously acquired from a single apical transducer position.

A major advantage of strain and strain rate imaging in wall motion analysis is the reduction of tethering and translational effects. 3DWMT potentially identifies more accurately than 2D tethering, dysfunctional from normal myocardial segments, and abnormal wall motion due to cardiac translation. This is possible because the true 3D motion is contained within the ultrasound dataset, which eliminates the effects of through-plane motion that may occur with 2D imaging.

While stress echo is a proven clinical tool, the interpretation of segmental wall motion requires experience and expertise and in this setting is largely subjective. Strain and strain rate imaging have each shown promise as an adjunct to stress echocardiography; infarct-involved segments, visually normokinetic segments supplied by stenotic arteries, and regional ischemia are reliably detected. Strain measures may also be useful for the determination of myocardial viability, as stunned myocardium displays reduced systolic strain rates that improve with dobutamine infusion. Since 3DWMT provides an objective method to detect and quantify wall motion, the application potentially improves reproducibility when used in combination with stress echo. Detailed and quantifiable wall motion parameters may add to the accuracy of stress testing so the right patients are sent on for further testing.

Diagnosis for Other Cardiovascular Disease

3DWMT is not only useful in the comprehensive assessment of myocardial deformation, but can potentially determine timing of deformation more accurately than 2D methods. Dyssynchrony of systolic strain as determined by 3DWMT may be valuable in the screening, selection and follow-up of patients who are candidates for cardiac resynchronization therapy (CRT). Fast acquisition and comprehensive information of all segments of the left ventricle (LV), facilitates the use of this method for patient selection and optimization of CRT devices immediately after implantation.

Since strains and strain rates are homogenously distributed across the myocardium, the detection of even subtle changes suggests myocardial dysfunction. Thus, 3DWMT has an important potential role in the diagnosis and management of virtually any disease that affects the myocardium. For example, anthracyclines are highly effective chemotherapeutic agents for breast cancer but their use is restricted by the frequent development of LV dysfunction and heart failure. Standard surveillance using the LV ejection fraction is often ineffective because the onset of clinical damage occurs late and the ejection fraction is load-dependent and fails to identify subclinical LV dysfunction. The ability of strain and strain rate imaging to efficiently monitor therapy, define the patient at risk, and predict later development of LV dysfunction and heart failure is exciting and promising. The ability for 3DWMT to give a more accurate representation of heart function may help physicians better make treatment decisions.

Although systolic strain and strain rates have received the greatest attention, changes in diastolic strain measures may also portend cardiac disease. For example, patients with restrictive cardiomyopathy have lower early diastolic strain rates than those with constrictive pericarditis Strain rates measured in early diastole may also be able to differentiate hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy from physiologic hypertrophy in athletes.

Workflow and Patient Care

3DWMT has the potential ability to improve patient care and reduce health care costs by identifying heart disease more accurately and at an earlier stage. Studies have shown that 3DWMT is a simple and reproducible technique, and that compared to 2D speckle tracking, it more quickly and completely analyzes myocardial deformation. Coupled with rapid, semi-automated volume, LV ejection fraction and mass determinations, 3DWMT can increase the efficiency and productivity of the echo lab. As noted above, 3DWMT has the ability to detect subclinical disease and visualize small reductions in strain or strain rate as well as view subtle abnormalities in ventricular volume and function. Earlier diagnoses will also save valuable healthcare resources as disease can be treated in its earlier stages.

Complete analysis with 3D wall motion tracking can be completed in a few minutes and the method can be performed either on-line directly on the ultrasound system or off-line using a dedicated workstation. The acquired data is stored in a raw data format which allows off-line analysis with the same accuracy as the on-line procedure. Future parametric techniques can be retrospectively applied to stored datasets. University Hospitals Case Medical Center performs 3DWMT analysis on such a workstation housed in the echo reading area and are storing a DICOM clip of the analysis on an image analysis system.

The introduction of 3D wall motion tracking marks the beginning of a new era in cardiac ultrasound. Utilizing state-of-the-art ultrasound, cardiac function in full 3D information is now available and can be performed during the examination. 3D wall motion tracking provides clinicians with a more robust method to gain global and regional cardiac function information in everyday practice, including new and exciting parameters such as twist and torsion.

Related Content

Epsilon Launches EchoInsight Pro Starter Configuration
News | Cardiovascular Ultrasound | February 15, 2019
Epsilon Imaging recently launched the new EchoInsight Pro Starter configuration for those programs that may be budget...
A view of GE Healthcare's volume max, or Vmax, which allows for nearly triple the frame rate speeds on 3-D TEE in a single beat over previous generation systems.

A view of GE Healthcare's volume max, or Vmax, which allows for nearly triple the frame rate speeds on 3-D TEE in a single beat over previous-generation systems.  

Feature | Cardiovascular Ultrasound | January 31, 2019 | Dave Fornell, Editor
The higher expense and lower frame rates of 3-D...
ASE Releases New Guide to Performing Comprehensive Transthoracic Echo Exams
News | Cardiovascular Ultrasound | January 21, 2019
January 21, 2019 – Medical experts have released “...
Videos | Cardiovascular Ultrasound | December 12, 2018
This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound.
Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
Bay Labs and Northwestern Medicine Enroll First Patient in AI Echocardiography Study
News | Cardiovascular Ultrasound | November 19, 2018
Medical artificial intelligence (AI) company Bay Labs and Northwestern Medicine announced that the first patient has...
Vygon and Sonoscanner Partnering on New Ultrasound System for Catheter Placement Guidance
News | Cardiovascular Ultrasound | October 31, 2018
Vygon, an international group specialized in single-use medical devices, and French company Sonoscanner announced the...
Hitachi Supports ASE Foundation Cardiovascular Outreach Mission in West Virginia
News | Cardiovascular Ultrasound | October 29, 2018
Hitachi Healthcare Americas participated in the cardiovascular screening and diagnostic triage event that took place...
Case Study | Cardiovascular Ultrasound | September 25, 2018
Suboptimal cardiovascular ultrasound imaging can produce transthoracic echocardiograms (TTEs) that are inconclusive,
LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
September 19, 2018 — DiA Imaging Analysis Ltd.
Overlay Init